Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease

American Heart Journal

Volumn 154, Issue 4, 2007, Pages 751-758

  Horne, Benjamin D ^a,b   Camp, Nicola J ^b   Carlquist, John F ^a,c   Muhlestein, Joseph B ^a,c   Kolek, Matthew J ^a   Nicholas, Zachary P ^a   Anderson, Jeffrey L ^a,c  

^a LDS HOSPITAL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; STROMELYSIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENETIC DISORDER; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

AGED; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIABETIC ANGIOPATHIES; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 34548742979     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.06.030     Document Type: Article

References (30)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 15-26
2. Wilson P.W., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
3. Nora J.J., Lortscher R.H., Spangler R.D., et al. Genetic epidemiologic study of early-onset ischemic heart disease. Circulation 61 (1980) 503-508
4. Barrett-Connor E., and Khaw K.T. Family history of heart attack as an independent predictor of death due to cardiovascular disease. Circulation 69 (1984) 1065-1069
5. van der Wal A.C., Becker A.E., van der Luce C.M., et al. Site of intimal rupture or erosion of thrombosis in coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89 (1994) 36-44
6. Libby P. Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am J Cardiol 86 Suppl (2000) 3J-9J
7. Libby P. What have we learned about the biology of atherosclerosis? The role of inflammation. Am J Cardiol 88 Suppl (2001) 3J-6J
8. Galis Z.S., Sukhova G.K., Lark M.W., et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94 (1994) 2493-2503
9. Orbe J., Fernandez L., Rodriguez J.A., et al. Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed. Atherosclerosis 170 (2003) 269-276
10. Ye S., Watts G.F., Mandalia S., et al. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J 73 (1995) 209-215
11. Terashima M., Akita H., Kanazawa J., et al. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction. Circulation 99 (1999) 2717-2719
12. Humphries S.E., Luong L., Talmud P.J., et al. The 5A/6A polymorphism of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Atherosclerosis 139 (1998) 49-56
13. de Maat M.P.M., Jukema J.W., Ye S., et al. Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis. Am J Cardiol 83 (1999) 852-856
14. Liu P.Y., Li Y.H., Chan S.H., et al. Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome. Am J Cardiol 98 (2006) 1012-1017
15. Zhang B., Ye S., Herrmann S.M., et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99 (1999) 1788-1794
16. Wang J., Warzecha D., Wilcken D., et al. Polymorphism in the gelatinase B gene and the severity of coronary arterial stenosis. Clin Sci (Lond) 101 (2001) 87-92
17. Cho H.J., Chae I.H., Park K.W., et al. Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention. J Hum Genet 47 (2002) 88-91
18. Lamblin N., Bauters C., Hermant X., et al. Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9, and MMP-12 genes as determinants of aneurysmal coronary artery disease. J Am Coll Cardiol 40 (2002) 43-48
19. Ye S., Gale C.R., and Martyn C.N. Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease. Eur Heart J 24 (2003) 1668-1671
20. Morgan A.R., Zhang B., Tapper W., et al. Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease. J Mol Med 81 (2003) 321-326
21. Nojiri T., Morita H., Imai Y., et al. Genetic variations of matrix metalloproteinase-1 and -3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese. Int J Cardiol 92 (2003) 181-186
22. Zhou X., Huang J., Chen J., et al. Haplotype analysis of the matrix metalloproteinase 3 gene and myocardial infarction in a Chinese Han population. The Beijing atherosclerosis study. Thromb Haemost 92 (2004) 867-873
23. Beyzade S., Zhang S., Wong Y., et al. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J Am Coll Cardiol 41 (2003) 2130-2137
24. Pearce E., Tregouet D.A., Samnegard A., et al. Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction. Circ Res 97 (2005) 1070-1076
25. Krex D., Rohl H., Konig I.R., et al. Tissue inhibitor of metalloproteinases-1, -2, and -3 polymorphisms in a white population with intracranial aneurysms. Stroke 34 (2003) 2817-2821
26. Yamada Y., Izawa H., Ichihara S., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347 (2002) 1916-1923
27. Hirashiki A., Yamada Y., Murase Y., et al. Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol 42 (2003) 1429-1437
28. Horne B.D., Carlquist J.F., Cannon-Albright L.A., et al. High-resolution characterization of linkage disequilibrium structure and selection of tagging single nucleotide polymorphisms: application to the cholesteryl ester transfer protein gene. Ann Hum Genet 70 (2006) 524-535
29. Kathiresan S., Larson M.G., Vasan R.S., et al. Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 113 (2006) 1415-1423
30. Crawford D.C., Sanders C.L., Qin X., et al. Genetic variation is associated with C-reactive protein levels in the third National Health and Nutrition Examination Survey. Circulation 114 (2006) 2458-2465